The ongoing turbulence in global trade policy, particularly the re-escalation of tariffs on medical supplies from China and other countries, is weighing heavily on US healthcare operations. Sweeping US trade policy shifts this year are sparking great concern, but while 2025 has seen unprecedented tariff escalations and supply chain volatility, the concern began mounting as early as May 2024, when the Biden administration reignited trade tensions by expanding tariffs on Chinese medical imports.
What happens when a veteran perioperative leader walks away from…
The migration of surgical cases from inpatient settings to ambulatory…
About the survey Data for the Career/Salary Survey were collected…